{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825893775818624.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1053/j.gastro.2008.07.008"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0016508508013164?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0016508508013164?httpAccept=text/plain"}}],"dc:title":[{"@value":"HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825893775818628","@type":"Researcher","foaf:name":[{"@value":"Man–Fung Yuen"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893775818496","@type":"Researcher","foaf:name":[{"@value":"Danny Ka–Ho Wong"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893775818626","@type":"Researcher","foaf:name":[{"@value":"James Fung"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893775818629","@type":"Researcher","foaf:name":[{"@value":"Philip Ip"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893775818631","@type":"Researcher","foaf:name":[{"@value":"David But"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893775818630","@type":"Researcher","foaf:name":[{"@value":"Ivan Hung"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893775818624","@type":"Researcher","foaf:name":[{"@value":"Kevin Lau"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893775818625","@type":"Researcher","foaf:name":[{"@value":"John Chi–Hang Yuen"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893775818627","@type":"Researcher","foaf:name":[{"@value":"Ching–Lung Lai"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00165085"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00165085"}],"prism:publicationName":[{"@value":"Gastroenterology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2008-10","prism:volume":"135","prism:number":"4","prism:startingPage":"1192","prism:endingPage":"1199"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0016508508013164?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0016508508013164?httpAccept=text/plain"}],"createdAt":"2008-07-17","modifiedAt":"2023-05-19","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002218464353408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Application of a Newly Developed High-Sensitivity HBsAg Chemiluminescent Enzyme Immunoassay for Hepatitis B Patients with HBsAg Seroclearance"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168880827008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710773454592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re‐evaluation of <scp>HB</scp>sAg seroclearance"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617685285632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"HBx increases EGFR expression by inhibiting miR129–5p function"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168116408320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hepatic flares promote rapid decline of serum hepatitis B surface antigen (HBsAg) in patients with HBsAg seroclearance: A long‐term follow‐up study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567188226381568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"DHX9 regulates production of hepatitis B virus-derived circular RNA and viral protein levels"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584339749273600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Kinetics of HBcrAg and HBsAg using highly sensitive iTACT assays in chronic hepatitis B patients with HBsAg seroclearance"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848655057795456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pevonedistat, a Neuronal Precursor Cell‐Expressed Developmentally Down‐Regulated Protein 8–Activating Enzyme Inhibitor, Is a Potent Inhibitor of Hepatitis B Virus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567435460992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A global scientific strategy to cure hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1390006895523803776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679770642688","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development of hepatocellular carcinoma after seroclearance of hepatitis surface antigen"},{"@language":"ja","@value":"ＨＢｓ抗原陰性化後に肝細胞癌を発症したＨＢＶキャリア症例"},{"@value":"症例報告 HBs抗原陰性化後に肝細胞癌を発症したHBVキャリア症例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク HBs コウゲン インセイカ ゴ ニ カン サイボウガン オ ハッショウ シタ HBV キャリア ショウレイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679772059264","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Comparison of each HBs antigen assay and it's clinical utility"},{"@language":"ja","@value":"HBs抗原の測定法と臨床的意義"},{"@language":"ja-Kana","@value":"HBs コウゲン ノ ソクテイホウ ト リンショウテキ イギ"},{"@value":"Comparison of each HBs antigen assay and it^|^apos;s clinical utility"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1053/j.gastro.2008.07.008"},{"@type":"CROSSREF","@value":"10.1128/jcm.00726-13_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.1111/jvh.13557_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.1111/liv.12980_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.2957/kanzo.55.310_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.2957/kanzo.52.176_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2020.06.018_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.1111/hepr.12533_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.1002/jmv.29109_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.1002/hep.30491_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.18632/oncotarget.25104_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.1016/s2468-1253(19)30119-0_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.5783-20_references_DOI_7POqu51EcfzWLEYQJ5Pjf76BekZ"}]}